SCHEMBL2219869

SCHEMBL2219869

CC1=C(C(=Cc2ccc(S(C)(=O)=O)cc2)C(=O)O)c2cc(F)ccc2C1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 10/20 0.57
▸ PTGS2 P35354 6/20 0.57
▸ AKR1C2 P52895 3/20 0.57
▸ AKR1C1 Q04828 3/20 0.57
▸ CYP1A2 P05177 1/20 0.45
▸ GLA P06280 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ EDNRA P25101 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ PMP22 Q01453 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8521003 0.90 PTGS2 (0.45) AKR1C3PTGS2AKR1C2AKR1C1
SCHEMBL15571317 0.90 AKR1C3 (0.52) AKR1C3PTGS2AKR1C2AKR1C1
SCHEMBL5138929 0.89 AKR1C3 (0.43) AKR1C3PTGS2AKR1C2AKR1C1CYP1A2
SCHEMBL8428502 0.85 PTGS2 (0.38) AKR1C3PTGS2AKR1C2AKR1C1
SCHEMBL15572316 0.85 AKR1C3 (0.58) AKR1C3PTGS2AKR1C2AKR1C1
SCHEMBL8796288 0.85 AKR1C3 (0.48) AKR1C3PTGS2AKR1C2AKR1C1
SCHEMBL2224238 0.85 AKR1C3 (0.47) AKR1C3PTGS2AKR1C2AKR1C1
SCHEMBL2222865 0.85 AKR1C3 (0.47) AKR1C3PTGS2AKR1C2AKR1C1
SCHEMBL2223120 0.84 PTGS2 (0.38) AKR1C3PTGS2AKR1C2AKR1C1CYP1A2
SCHEMBL8506321 0.84 PTGS2 (0.38) AKR1C3PTGS2AKR1C2AKR1C1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011088474-A2 SULINDAC AND SULINDAC DERIVATIVES AND THEIR USES RELATED TO INFECTION Zirus, Inc. (US) 2011-07-21 — — WO disclosed
US-4423075-A Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic acid AYERST, MCKENNA & HARRISON INC. (CA) 1983-12-27 — — US disclosed
Send feedback